Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Objective: In November 1993, Dutch health authorities advised that women planning a pregnancy should take folic acid in the periconceptional period to reduce the risk of fetal neural tube defects. In the autumn of 1995 a national campaign was organized to inform women and health care professionals in a systematic way.
Methods: We assessed the awareness and behaviour of women at their first or second antenatal visit in two surveys in the spring of 1994 and the autumn of 1995, in order to evaluate the impact of non-systematic information during that period, and to collect baseline data to evaluate the effect of the national folic acid campaign. The two surveys were carried out in the north and the west of The Netherlands.
Results: The proportion of women who had heard of folic acid increased from 28% to 78%. The proportion that used folic acid during any period in pregnancy increased from 7.8% to 26%. The proportion that took folic acid tablets during the whole of the recommended period increased from 0.8 to 4.4%. In the group of women who did not take folic acid, the proportion who did “not like to use anything during pregnancy” decreased, as did the proportion who did “not think it is useful”.
Conclusion: In The Netherlands, non-systematic information about periconceptional folic acid use has already led to significant changes in awareness and behaviour before the start of the national folic acid campaign.
- Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995
European Journal of Clinical Pharmacology
Volume 54, Issue 4 , pp 329-331
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Key words Folic acid
- Neural tube defects
- Public health education
- Industry Sectors
- Author Affiliations
- A1. Social Pharmacy and Pharmacoepidemiology, Groningen Institute for Drug Studies, Antonius Deusinglaan 2, 9714 AW Groningen, The Netherlands Tel.: +31-50-363-3330 Fax: +31-50-363-3311 e-mail: L.T.W.de.Jong-van.den.Berg@farm.rug.nl, NL
- A2. EUROCAT, Department of Medical Genetics, University of Groningen, Groningen, The Netherlands, NL
- A3. TNO Prevention and Health, Leiden, The Netherlands, NL